BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26695504)

  • 21. Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.
    Wale A; Miles KA; Young B; Zammit C; Williams A; Quin J; Dizdarevic S
    Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):105-15. PubMed ID: 24030667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy.
    Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A; Lazzi S
    J Nucl Med; 1998 May; 39(5):822-5. PubMed ID: 9591583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area.
    Kresnik E; Gallowitsch HJ; Mikosch P; Gomez I; Lind P
    J Nucl Med; 1997 Jan; 38(1):62-5. PubMed ID: 8998152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [99mTc-MIBI scintigraphy of hypofunctional thyroid nodules. Comparison of planar and SPECT imaging].
    Schenke S; Zimny M; Rink T; Stahl U; Fritzel M; Klett R
    Nuklearmedizin; 2014; 53(3):105-10. PubMed ID: 24510009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic performance of (99m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis.
    Treglia G; Caldarella C; Saggiorato E; Ceriani L; Orlandi F; Salvatori M; Giovanella L
    Endocrine; 2013 Aug; 44(1):70-8. PubMed ID: 23529672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [99mTc]MIBI scintigraphy in a patient with thyroid follicular neoplasm: a case report and review of literature.
    Arabi M; Zamani H; Soltanabadi M; Kalhor L
    Nucl Med Rev Cent East Eur; 2021; 24(2):118-119. PubMed ID: 34382681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 99mTc-methoxyisobutyl isonitrile and 201T1 scintigraphy in visualization of suppressed thyroid tissue.
    Erdil TY; Onsel C; Kanmaz B; Caner B; Sönmezoğlu K; Ciftçi I; Turoğlu T; Kabasakal L; Sayman HB; Uslu I
    J Nucl Med; 2000 Jul; 41(7):1163-7. PubMed ID: 10914905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
    Nikiforov YE; Ohori NP; Hodak SP; Carty SE; LeBeau SO; Ferris RL; Yip L; Seethala RR; Tublin ME; Stang MT; Coyne C; Johnson JT; Stewart AF; Nikiforova MN
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3390-7. PubMed ID: 21880806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
    Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
    Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interobserver Agreement of Planar and SPECT Tc99m-MIBI Scintigraphy for the Assessment of Hypofunctioning Thyroid Nodules.
    Schenke S; Klett R; Acker P; Rink T; Kreissl MC; Zimny M
    Nuklearmedizin; 2019 Jun; 58(3):258-264. PubMed ID: 31075799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of different histological subtypes of thyroid nodules classified with 99mTc-methoxy-isobutyl-isonitrile imaging and Thyroid Imaging Reporting And Data System.
    Schenke SA; Klett R; Wagner PR; Mott S; Zimny M; Feek U; Kreissl MC
    Nucl Med Commun; 2021 Jan; 42(1):73-80. PubMed ID: 33122502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of scintigraphy with tumor-seeking agents in the diagnosis and preoperative staging of malignant thyroid nodules.
    Casara D; Rubello D; Saladini G
    Biomed Pharmacother; 2000 Jul; 54(6):334-6. PubMed ID: 10989969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioguided thyroidectomy for follicular tumors: Multicentric experience.
    Parmeggiani D; Gambardella C; Patrone R; Polistena A; De Falco M; Ruggiero R; Cirocchi R; Sanguinetti A; Cuccurullo V; Accardo M; Avenia N; Docimo G; Tolone S; Bassi V; Docimo L; Conzo G
    Int J Surg; 2017 May; 41 Suppl 1():S75-S81. PubMed ID: 28506419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter.
    Karayalçin U; Ciftçi F; Boz A; Boz S; Karayalçin B
    Ann Nucl Med; 1997 Nov; 11(4):285-90. PubMed ID: 9460519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule.
    Hurtado-López LM; Arellano-Montaño S; Torres-Acosta EM; Zaldivar-Ramirez FR; Duarte-Torres RM; Alonso-De-Ruiz P; Martínez-Duncker I; Martínez-Duncker C
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1273-9. PubMed ID: 15133637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.
    Nakahara H; Noguchi S; Murakami N; Hoshi H; Jinnouchi S; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
    J Nucl Med; 1996 Jun; 37(6):901-4. PubMed ID: 8683308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
    Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.